• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGNI
    Picture of GNI logo

    2160 — GNI Share News

    ¥2,6900.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    • Market Cap
      ¥177bn
    • Enterprise Value
      ¥185bn
    • Revenue
      ¥27bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 2160 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    2160 Dividends
    • Brief: GNI Group says exercise of options

      14/06/2017 09:07
    • Brief: GNI Group announces exercise of options

      12/06/2017 08:27
    • Corrected: OFFICIAL-BRIEF-GNI Group to acquire Berkeley Advanced Biomaterials through GNI USA(April 18)

      19/04/2017 10:22
    • Brief: GNI Group to acquire Berkeley Advanced Biomaterial through GNI USA

      18/04/2017 09:41
    • 2017 group forecast(IFRS)

      18/04/2017 09:05
    • 2016 group results (IFRS)

      15/02/2017 06:00
    • 2016 group forecast(IFRS)

      14/02/2017 01:20
    • 9-MTH group results (IFRS)

      10/11/2016 06:00
    • Brief: GNI Group says investigational new drug approval by CFDA

      08/09/2016 09:26
    • Brief: GNI Group gets approval for clinical trial in China for drug of diabetic nephropathy

      17/08/2016 09:16
    • 6-MTH group results (IFRS)

      10/08/2016 07:00
    • Brief: GNI Group unit gets manufacture and marketing approval of Etuary in China

      03/08/2016 06:46
    • Q1 group results (IFRS)

      12/05/2016 07:00
    • 2015 group results (IFRS)

      15/02/2016 08:15
    • 9-MTH group results

      12/11/2015 06:00
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.